Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CFHR5 Monoclonal Antibody (3E1E10)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA531677
Description
MA5-31677 has been tested in indirect ELISA.
This gene is a member of a small complement factor H (CFH) gene cluster on chromosome 1. Each member of this gene family contains multiple short consensus repeats (SCRs) typical of regulators of complement activation. The protein encoded by this gene has nine SCRs with the first two repeats having heparin binding properties, a region within repeats 5-7 having heparin binding and C reactive protein binding properties, and the C-terminal repeats being similar to a complement component 3 b (C3b) binding domain. This protein co-localizes with C3, binds C3b in a dose-dependent manner, and is recruited to tissues damaged by C-reactive protein. Allelic variations in this gene have been associated, but not causally linked, with two different forms of kidney disease: membranoproliferative glomerulonephritis type II (MPGNII) and hemolytic uraemic syndrome (HUS).
Specifications
CFHR5 | |
Monoclonal | |
1 mg/mL | |
PBS with 0.05% sodium azide | |
Q9BXR6 | |
CFHR5 | |
Purified recombinant fragment of human CFHR5 (AA: 344-569) expressed in E. coli. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG1 |
ELISA, Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
3E1E10 | |
Unconjugated | |
CFHR5 | |
CFHL5; CFHR5; CFHR5D; complement factor H related 5; complement factor H-related 5; complement factor H-related protein 5; factor H-related protein 5; FHR5; FHR-5 | |
Mouse | |
Protein G | |
RUO | |
81494 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction